Diabetes, oxidative stress, and antioxidants: A review

Journal of Biochemical and Molecular Toxicology - Tập 17 Số 1 - Trang 24-38 - 2003
Alice Maritim1, Ruth A. Sanders2, John B. Watkins2
1Moi University College of Health Sciences, Eldoret, Kenya
2Medical Sciences Program, Indiana University School of Medicine, Bloomington, IN, USA

Tóm tắt

AbstractIncreasing evidence in both experimental and clinical studies suggests that oxidative stress plays a major role in the pathogenesis of both types of diabetes mellitus. Free radicals are formed disproportionately in diabetes by glucose oxidation, nonenzymatic glycation of proteins, and the subsequent oxidative degradation of glycated proteins. Abnormally high levels of free radicals and the simultaneous decline of antioxidant defense mechanisms can lead to damage of cellular organelles and enzymes, increased lipid peroxidation, and development of insulin resistance. These consequences of oxidative stress can promote the development of complications of diabetes mellitus. Changes in oxidative stress biomarkers, including superoxide dismutase, catalase, glutathione reductase, glutathione peroxidase, glutathione levels, vitamins, lipid peroxidation, nitrite concentration, nonenzymatic glycosylated proteins, and hyperglycemia in diabetes, and their consequences, are discussed in this review. In vivo studies of the effects of various conventional and alternative drugs on these biomarkers are surveyed. There is a need to continue to explore the relationship between free radicals, diabetes, and its complications, and to elucidate the mechanisms by which increased oxidative stress accelerates the development of diabetic complications, in an effort to expand treatment options. © 2003 Wiley Periodicals, Inc. J Biochem Mol Toxicol 17:24–38, 2003; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.10058

Từ khóa


Tài liệu tham khảo

10.2337/diab.32.3.247

10.1126/science.388619

10.2337/diabetes.31.9.808

10.1517/03009734000000053

10.1007/BF02703744

10.1016/S0026-0495(00)80082-7

10.2337/diabetes.48.1.1

10.2337/diab.40.4.405

Chang KC, 1993, Possible superoxide radical‐induced alteration of vascular reactivity in aortas from streptozotocin‐treated rats, J Pharmacol Exp Ther, 266, 992

10.1016/0891-5849(94)00202-U

10.1016/0076-6879(90)86093-B

10.1016/0006-2952(93)90124-F

10.2337/diabetes.40.3.344

10.1016/0014-5793(90)80974-N

10.1042/bj2450243

10.1016/0014-5793(93)81706-6

Tsai EC, 1994, Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM, Diabetes, 43, 1010, 10.2337/diab.43.8.1010

10.1172/JCI117396

10.1093/ndt/11.supp5.13

10.1016/S0006-291X(05)80875-7

10.1007/s005920170007

10.2337/diab.46.2.S19

10.1073/pnas.91.16.7742

10.1002/biof.5520100211

Kador PF, 1984, Diabetic and galactosaemic cataracts, Ciba Found Symp, 106, 110

10.2337/diacare.15.12.1902

10.1076/ceyr.16.1.34.5113

Gonzalez AM, 1986, Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens, Diabetes, 35, 1200, 10.2337/diab.35.11.1200

10.1016/0026-0495(86)90180-0

Williamson JR, 1993, Hyperglycemic pseudohypoxia and diabetic complications, Diabetes, 42, 801, 10.2337/diab.42.6.801

10.1016/0168-8227(89)90013-2

Ramalho JS, 1996, Role of glycation in human lens protein structure change, Eur J Ophthalmol, 6, 155, 10.1177/112067219600600211

10.1097/00005072-199712000-00004

10.2337/diabetes.47.11.1779

Hounsom L, 1998, A lipoic acid‐gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy, Diabetologia, 41, 839, 10.1007/s001250050996

10.2337/diabetes.49.6.1006

10.1016/0014-2999(95)00451-P

10.1016/S0014-2999(96)00804-7

10.1097/00005072-199809000-00001

10.1007/s004010050764

10.1007/BF01940542

Fernyhough P, 1999, Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy, Diabetes, 48, 881, 10.2337/diabetes.48.4.881

10.1007/978-3-642-83104-1

10.1016/S0008-6363(00)00054-7

10.1006/phrs.1999.0614

10.1016/0891-5849(91)90174-2

Asayama K, 1989, Antioxidant enzyme status and lipid peroxidation in various tissues of diabetic and starved rats, Diabetes Res, 12, 85

10.1016/0891-5849(88)90036-6

Pierrefiche G, 1993, Antioxidant activity of melatonin in mice, Res Commun Chem Pathol Pharmacol, 80, 211

Thompson KH, 1993, Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats, Res Commun Chem Pathol Pharmacol, 80, 187

Kaul N, 1995, Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy, Nutrition, 11, 551

10.1007/BF00240060

10.1023/A:1011000327529

10.1002/1099-0461(2001)15:1<41::AID-JBT5>3.0.CO;2-Z

10.1002/jbt.13

10.1002/(SICI)1099-0461(2000)14:4<189::AID-JBT2>3.0.CO;2-V

10.1002/1099-0461(2000)14:6<329::AID-JBT5>3.0.CO;2-G

10.1080/109158199225440

10.1016/S0891-5849(99)00012-X

10.1159/000056072

10.1007/s005920070033

10.1006/phrs.2000.0705

10.1111/j.1600-079X.1998.tb00545.x

10.1159/000012829

10.1080/15216540050033177

10.2337/diabetes.49.8.1381

10.1016/S0891-5849(98)00129-4

10.1006/phrs.2000.0772

10.1515/CCLM.1998.137

Obrosova IG, 1999, Effect of dietary taurine supplementation on GSH and NAD(P)‐redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens, Invest Ophthalm Vis Sci, 40, 680

10.1016/S0014-2999(00)00286-7

10.1046/j.1365-2362.2001.00832.x

10.1034/j.1600-079X.2000.290207.x

10.1016/S0009-2797(00)00168-X

10.1002/jbt.11

10.1007/s001250051290

Kocak G, 2000, α‐Lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin‐diabetes, Diab Nutr Metab, 13, 308

10.1002/food.19950390402

10.2337/diabetes.50.3.667

10.1007/s11745-000-0639-2

10.1053/meta.2001.24914

10.1146/annurev.bi.52.070183.003431

Josephy PD, 1997, Molecular Toxicology

Gregus Z, 1996, Lipoic acid impairs glycine conjugation of benzoic acid and renal excretion of benzoylglycine, Drug Metab Disp, 24, 682

10.1002/1520-7560(0000)9999:9999<::AID-DMRR153>3.0.CO;2-S

10.1016/0165-1218(93)90095-U

10.2337/diab.46.11.1853

10.1016/0891-5849(93)90512-S

10.1007/s005920070012

10.1007/BF02253360

10.1016/S0899-9007(97)00110-X

Martinoli L, 1993, Plasma retinol and alpha‐tocopherol concentrations in insulin‐dependent diabetes mellitus: Their relationship to microvascular complications, Int J Vitam Nutr Res, 63, 87

10.1055/s-2007-1001693

Garg MC, 1996, Effect of vitamin E supplementation on antioxidant status of diabetic rats, Med Sci Res, 24, 325

10.1007/s001250050883

10.1161/01.HYP.35.2.655

10.1076/ceyr.21.4.814.5545

10.1042/bj2560205

10.1016/0891-5849(91)90040-A

10.1016/0076-6879(84)06010-9

10.1038/414813a

10.1016/S0165-0173(96)00016-1

Brownlee M, 1990, Diabetes Mellitus: Theory and Practice, 279

10.1016/S0898-6568(97)00131-9

Aruna RV, 1999, Effect of betacarotene on protein glycosylation in alloxan induced diabetic rats, Indian J Exp Biol, 37, 399

10.1097/00005344-200008000-00017

10.1089/jop.2000.16.149

10.1002/(SICI)1099-0461(1998)12:4<219::AID-JBT4>3.0.CO;2-O

Lu SC, 1997, Progressive defect in biliary GSH secretion in streptozotocin‐induced diabetic rats, Am J Physiol, 272, G374

10.1007/BF01081736

Watkins JB, 1995, Diabetes mellitus‐induced alterations of hepatobiliary function, Pharmacol Rev, 47, 1

10.1016/S0167-4838(00)00276-4

Thông tin
Thông tin xuất bản

Journal of Biochemical and Molecular Toxicology

Tập 17 Số 1

24-38

Thông tin tác giả